Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults

NCT00534495 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Juvenile Idiopathic Arthritis

Interventions

BIOLOGICAL: Rilonacept

Sponsor

Montefiore Medical Center

Collaborators

[object Object]